Document is current
Any future updates will be listed below
-
Authors
Tsamitros, N.
Gutwinski, S.
Beck, A.
Lange Mussons, S.
Sebold, M.
Schöneck, R.
Wolbers, T.
Bermpohl, F.
Heinz, A.
Lütt, A.
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 26 July 2024
Accepted: 25 November 2024
First Online: 18 December 2024
Declarations
:
: NT, SG, AB, SLM and AL cooperate with neomento GmbH without financial interests for the development of a VR software for VirtuCueR, a VR treatment for patients with alcohol use disorder, currently developed and supported by the Berlin Institute of Health (Digital Health Accelerator Program) and Charité - Universitätsmedizin Berlin. TW is a shareholder of neomento GmbH. MS, RS, FB, AH have no competing interest to declare.
: Ethical approval was provided by the local Ethics Committee of Charité - Universitätsmedizin Berlin (EA1/190/22, 23.05.2023). All participants gave written informed consent prior to enrolment. All methods were carried out in accordance with the Declaration of Helsinki and its amendments.
